The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: cefazolin     Quarter: 2016Q3

Total Records: 134     Number of Pages: 7

DRUGNAME PT EventCount
CEFAZOLIN Toxic epidermal necrolysis 6
CEFAZOLINE Drug reaction with eosinophilia and systemic symptoms 6
CEFAZOLIN Acute generalised exanthematous pustulosis 4
CEFAZOLIN Anaphylactic shock 4
CEFAZOLIN Electrolyte imbalance 4
CEFAZOLIN Erythema 4
CEFAZOLIN Pancytopenia 4
CEFAZOLINE Liver injury 4
CEFAZOLIN Hypotension 3
CEFAZOLIN Pyrexia 3
CEFAZOLIN Acute kidney injury 2
CEFAZOLIN Cardiac arrest 2
CEFAZOLIN Drug hypersensitivity 2
CEFAZOLIN Kounis syndrome 2
CEFAZOLIN Nausea 2
CEFAZOLIN Tachycardia 2
CEFAZOLIN Urticaria 2
Cefazoline Blood urea decreased 2
Cefazoline Blood uric acid increased 2
Cefazoline Foetal exposure during pregnancy 2

Total Records: 134     Number of Pages: 7